Clinical Trial Update: Markers of Prognosis and Response to Therapy in Patients With Metastatic Brain Tumors Undergoing Stereotactic Radiosurgery (SRS)

View source ↗

Summary

This study investigates biomarkers that predict prognosis and response to stereotactic radiosurgery in patients with brain metastases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases

Snippet

Sponsor: Swedish Medical Center | Conditions: Metastatic Brain Tumor | Status: UNKNOWN